Centiva Capital LP Takes $543,000 Position in STAAR Surgical (NASDAQ:STAA)

Centiva Capital LP purchased a new position in STAAR Surgical (NASDAQ:STAA - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 22,368 shares of the medical instruments supplier's stock, valued at approximately $543,000.

Several other institutional investors have also added to or reduced their stakes in the business. Broadwood Capital Inc. lifted its holdings in shares of STAAR Surgical by 0.7% during the fourth quarter. Broadwood Capital Inc. now owns 10,848,631 shares of the medical instruments supplier's stock worth $263,513,000 after purchasing an additional 80,200 shares during the period. Bridgefront Capital LLC lifted its holdings in shares of STAAR Surgical by 27.2% during the fourth quarter. Bridgefront Capital LLC now owns 10,792 shares of the medical instruments supplier's stock worth $262,000 after purchasing an additional 2,306 shares during the period. BNP Paribas Financial Markets lifted its holdings in shares of STAAR Surgical by 107.2% during the fourth quarter. BNP Paribas Financial Markets now owns 75,983 shares of the medical instruments supplier's stock worth $1,846,000 after purchasing an additional 39,314 shares during the period. Ameriprise Financial Inc. lifted its holdings in STAAR Surgical by 45.0% in the fourth quarter. Ameriprise Financial Inc. now owns 184,140 shares of the medical instruments supplier's stock valued at $4,473,000 after acquiring an additional 57,129 shares during the period. Finally, Algert Global LLC lifted its holdings in STAAR Surgical by 134.8% in the fourth quarter. Algert Global LLC now owns 191,398 shares of the medical instruments supplier's stock valued at $4,649,000 after acquiring an additional 109,870 shares during the period. Institutional investors and hedge funds own 96.70% of the company's stock.

STAAR Surgical Stock Performance

Shares of STAA traded down $1.27 during trading hours on Tuesday, hitting $19.00. 914,394 shares of the stock were exchanged, compared to its average volume of 811,443. The stock's 50-day moving average price is $17.61 and its two-hundred day moving average price is $21.79. STAAR Surgical has a 12-month low of $13.50 and a 12-month high of $49.86. The company has a market cap of $940.99 million, a price-to-earnings ratio of -46.34 and a beta of 0.65.

Wall Street Analyst Weigh In

STAA has been the subject of a number of analyst reports. Jefferies Financial Group downgraded STAAR Surgical from a "buy" rating to a "hold" rating in a report on Wednesday, February 12th. StockNews.com downgraded STAAR Surgical from a "hold" rating to a "sell" rating in a report on Thursday, February 13th. Wells Fargo & Company initiated coverage on STAAR Surgical in a report on Monday, April 21st. They issued an "equal weight" rating and a $17.00 price target for the company. Needham & Company LLC reissued a "hold" rating on shares of STAAR Surgical in a report on Thursday, February 27th. Finally, BTIG Research cut STAAR Surgical from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 12th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat.com, STAAR Surgical presently has an average rating of "Hold" and an average price target of $24.63.

Insider Buying and Selling at STAAR Surgical

In related news, major shareholder Broadwood Partners, L.P. bought 259,616 shares of the company's stock in a transaction on Wednesday, February 12th. The stock was bought at an average cost of $14.96 per share, for a total transaction of $3,883,855.36. Following the acquisition, the insider now directly owns 11,137,623 shares in the company, valued at $166,618,840.08. This represents a 2.39% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders purchased a total of 1,742,581 shares of company stock worth $28,407,543 in the last three months. 1.00% of the stock is owned by corporate insiders.

STAAR Surgical Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.